EQT Life Sciences Leads Major Financing to Tackle Post-Amputation Pain EQT Life Sciences co-leads a $56 million Series D funding for Neuros Medical, aiming to promote FDA-approved pain relief technology for amputees.

EQT Life Sciences Leads Major Financing to Tackle Post-Amputation Pain #USA #Stockholm #Neuros_Medical #Altius #EQT_Life